Usefulness of fasting18F-FDG PET in identification of cardiac sarcoidosis

Journal of Nuclear Medicine

Volumn 45, Issue 12, 2004, Pages 1989-1998

  Okumura, Wataru ^a   Iwasaki, Tsutomu ^a   Toyama, Takuji ^a   Iso, Tatsuya ^a   Arai, Masashi ^a   Oriuchi, Noboru ^a   Endo, Keigo ^a   Yokoyama, Tomoyuki ^b   Suzuki, Tadashi ^c   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Fujioka General Hospital   (Japan)

Author keywords

18F FDG; Cardiac sarcoidosis; Fasting; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART SCINTISCANNING; HISTOPATHOLOGY; HUMAN; MALE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; BLOOD GLUCOSE; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 16644381260     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204-1211.
2. Perry A, Vuitch F. Cause of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119:167-172.
3. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43:372-376.
4. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103:253-258.
5. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107:330-334.
6. Le Guludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D. Myocardial sarcoidosis: clinical value of technetium-99m sestamibi tomoscintigraphy. Chest. 1994;106:1675-1682.
7. 18F-FDG PET. J Nucl Med. 2003;44:1030-1036.
8. Takeda N, Yokoyama I, Hiroi Y, et al. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation. 2002;105:1144-1145.
9. Hiraga H, Hiroe M, Iwai K, et al. Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Disease [in Japanese]. Tokyo, Japan: Japanese Ministry of Health and Welfare; 1993:23-24.
10. 18F-α-Methyl tyrosine PET studies in patients with brain tumors. J Nucl Med. 1999;40:399-405.
11. Amaral JF, Shearer JD, Mastrofrancesco B, Gann DS, Caldwell MD. Can lactate be used as a fuel by wounded tissue? Surgery. 1986;100:252-261.
12. Daley JM, Shearer JD, Mastrofrancesco B, Caldwell MD. Glucose metabolism in injured tissue: a longitudinal study. Surgery. 1990;107:187-192.
13. Newsholme P, Newsholme EA. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. Biochem J. 1989;261:211-218.
14. Mauel J. Macrophage activation by OM-85BV. Respiration. 1992;59(suppl 3):14-18.
15. Dannenberg AM Jr. Macrophages in inflammation and infection. N Engl J Med. 1974;293:489-493.
16. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
17. Merhige ME, Ekas R, Mossberg K, Taegtmeyer H, Gould KL. Catecholamine stimulation, substrate competition, and myocardial glucose uptake in conscious dogs assessed with positron emission tomography. Circ Res. 1987;61(suppl II):124-129.
18. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol. 1987;253:H107-H114.
19. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest. 1985;76:1819-1827.
20. Rosen Y, Athanassiades TJ, Moon S, Lyons HA. Nongranulomatous interstitial pneumonitis in sarcoidosis: relationship to development of epithelioid granulomas. Chest. 1978;74:122-125.
21. Teilum G. Morphogenesis and development of sarcoid lesions: similarities to the group of collagenosis. Acta Med Scand. 1964;425(suppl):14-18.
22. Spector WG, Heesom N. The production of granulomata by antigen-antibody complexes. J Pathol. 1969;98:31-39.
23. Unanue ER, Benacerraf B. Immunologic events in experimental hypersensitivity granulomas. Am J Pathol. 1973;71:349-360.
24. Jones ML, Warren JS. Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis. Lab Invest. 1992;66:498-503.
25. Warren JS, Jones ML, Flory CM. Analysis of monocyte chemoattractant protein 1-mediated lung injury using rat lung organ cultures. Am J Pathol. 1993;143:894-906.
26. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA. 1992;89:5371-5375.
27. Iyonaga K, Suga M, Ichiyasu H, Yamamoto T, Hiraga Y, Ando M. Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1998;15:165-172.
28. Soler P, Basset F. Morphology and distribution of cells of a sarcoid granuloma: ultrastructural study of serial sections. Ann NY Acad Sci. 1976;278:147-160.
29. Kita S, Tsuda T, Sugisaki K, Miyazaki E, Matsumoto T. Characterization of distribution of T lymphocyte subsets and activated T lymphocytes infiltrating into sarcoid lesions. Intern Med. 1995;34:847-855.
30. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.
31. Weisdorf DJ, Craddock PR, Jacob HS. Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. Blood. 1982;60:888-893.
32. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982;107:395-418.
33. Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir Dis. 1974;110:774-802.
34. Mitchell DN, Scadding JG, Heard BE, Hinson KFW. Sarcoidosis: histopathological definition and clinical diagnosis. J Clin Pathol. 1977;30:395-408.
35. Bulkley BH, Rouleau JR, Whitaker JQ, Strauss HW, Pitt B. The use of 201-thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 1977;72:27-32.
36. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med. 1988;85:189-193.
37. Yokoyama I, Momomura S, Ohtake T, et al. Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy. Eur J Nucl Med. 1998;25:736-743.
38. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28.
39. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: diagnosis with endomyocardial biopsy and treatment with corticosteroid. Am J Cardiol. 1978;42:143-146.
40. Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K. Steroid therapy in cardiac sarcoidosis: increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest. 1984;85:445-447.